Council hears plan to shift West Orange prescription benefits to self‑insured CVS Caremark; broker cites $1–2M potential savings

Lisa Narcissis of Fairview Insurance presented a proposal to the West Orange Township Council on March 3 to move the township’s prescription coverage from a fully insured model (Benard) to a self‑insured arrangement administered by CVS Caremark for active employees and retirees under age 65. Narcissis said the change would allow the township to capture negotiated pricing reductions and manufacturer and PBM rebates directly rather than having those retained by the existing carrier, and that those savings are the primary drivers of the projected 15–20% reduction in pharmacy costs.

Why it matters: Narcissis told councilors the township’s pharmacy premium is roughly $3 million annually and said Fairview used a three‑year lookback at West Orange claims to model the change; that analysis produced an annualized "potential" savings figure of about $1–$2 million. She emphasized that the figure is approximate because actual claims and utilization can vary year‑to‑year and because this year’s change would be implemented partway through the plan year.

The broker said members’ point‑of‑sale costs would not increase: "members would keep the same copays," she said, describing the contract terms as "equal‑to‑or‑better" for union and non‑union plan designs. Narcissis also described administrative details: members would automatically receive new ID cards and the transition would be passive (no new enrollment forms required), with employer file feeds used to move existing enrollments into the new carrier system. Nursing‑home and Medicare Advantage members were described as unaffected by this change.

Council questions focused on timing, risk and member protections. A six‑month implementation window with CVS Caremark was discussed as realistic for an on‑time launch; Narcissis described an interactive dashboard and quarterly reconciliation process so the township could track rebates and utilization. Council members asked how specialty or high‑cost drugs (including cancer therapies) would be handled. Narcissis said exceptions, prior‑authorizations and appeals processes would remain available so members on an established therapy would not be forced off medication without clinical review.

Union engagement and financial mechanics: Administration staff said union leaders had been briefed and that, because 2026 chapter‑78 calculations were already set using the Benard rates, the plan would not require immediate changes to 2026 employee cost‑sharing. Narcissis and staff said the rebate timing means the township likely would realize accounting gains after the quarterly closeouts rather than as an immediate reduction in 2026 premiums.

What the council did: The presentation was informational; no final council adoption or contract award for the prescription platform was recorded during the meeting. Councilors requested fuller supporting materials and legal/administrative backup before any final vote. The broker said Fairview had marketed the plan and already built a CVS Caremark implementation shell; she recommended a mid‑calendar‑year effective date if the council chose to proceed.

Next steps: Council members asked for contract backup, union confirmation and specific risk‑management language. Administration said it would circulate supporting documents and schedule further review before any binding action.

Ending: The presentation closed with administration and unions indicating coordination would continue; councilors asked the administration and Fairview to return with more detailed contract terms and implementation timelines.